A cadre of industry experts helping advance wireless health
Comprised of influential leaders in health care, wireless and mobile health, the Qualcomm Life Advisory Council (QLAC) is providing valued feedback to Qualcomm Life’s current and future offerings
Scott Barclay Surescripts
Nancy Brown American Heart Association
Ben Chu, MD Kaiser Permanente
Peter Diamandis, MD the X PRIZE Foundation
John Driscoll CEO, CareCentrix
Kieran Gallahue CareFusion
Major General Elder Granger, M.D. TRICARE Management Activity
Matthew Holt Health 2.0
James Hummer Luxemburg Capital; Whole Health Management
Don Jones CEO, Trial Fusion
Dean Kamen DEKA Research & Development Corporation
Francine Kaufman, MD National Diabetes Association; Medtronic
Ilene Klein, MD, FAAFP (Chair) Qualcomm Life, Inc.; Qualcomm Incorporated
Isaac Kohane, MD Harvard Medical School
Daniel Kraft, MD FutureMed
Joseph Kvedar, MD Partners HealthCare
Jack Lord, MD University of Miami Miller School of Medicine; UHealth-University of Miami Health System
Arnie Milstein, MD Pacific Business Group on Health; Mercer Benefits Consulting; Stanford CERC
Dana George Mead, Jr. Kleiner Perkins Caufield & Byers
Diego Miralles Janssen Healthcare Innovation; West Coast Research Center; Johnson & Johnson
Jean Rawlings UnitedHealth Group IT
Lee Shapiro Allscripts
Larry Smarr California Institute for Telecommunications and Information Technology (Calit2); University of California, San Diego
Mark Smith, MD California HealthCare Foundation
Lisa Suennen Managing Partner at Venture Valkyrie Consulting, LLC
Halle Tecco RockHealth
Eric Topol, MD Scripps Translational Science Institute
Dr. Chris Wasden Executive Director, Sorenson Center for Discovery and Innovation, University of Utah
Andrew Rose Watson, MD, MLitt, FACS CMIO, University of Pittsburgh Medical Center
John Wilbanks Kauffman Foundation
Scott BarclaySenior Vice President and Chief Strategy Officer, Surescripts
Scott Barclay is the senior vice president and chief strategy officer for Surescripts. In this role he works with the CEO and the Board of Directors to design and execute the firm's strategic direction. Scott is responsible for ensuring that the strategy is embedded in Surescripts' internal and external activities, including the firm's pricing, core value proposition to customers and approach to ecosystem innovation that will lower health care costs and improve patient outcomes by leveraging the Surescripts nationwide network. Scott joined Surescripts in July 2008, bringing an in-depth understanding of e-prescribing, the rapidly evolving HIT environment and experience from strategic consulting and investment banking. Before Surescripts, Scott most recently served as the general manager for physician connectivity at CVS Caremark, overseeing the firm's approach to eHealth as a retailer and pharmacy benefit manager while also running iScribe, a subsidiary e-prescribing company. Scott held the GM role after a number of years serving in the CVS/pharmacy operations and pharmacy innovation groups. Prior to CVS Caremark, Scott worked for the Boston Consulting Group in Washington, DC, and the investment banking and capital markets desk for Banc of America Securities in New York, San Francisco and London. Scott holds a liberal arts degree in history from the University of Virginia and an MBA from INSEAD, Paris, France.back to top
Nancy BrownCEO, American Heart Association
Nancy Brown has been chief executive officer of the American Heart Association (AHA) since 2009. The AHA is widely known and highly respected as the world's largest voluntary health organization dedicated to preventing, treating and defeating cardiovascular diseases and stroke. During her tenure as CEO, the AHA has become a global leader in the discovery and dissemination of heart disease and stroke science. Notably, under Nancy's leadership the AHA announced its bold new 2020 health impact goal: To improve the cardiovascular health of all Americans by 20% while reducing deaths from cardiovascular diseases and stroke by 20%. Nancy's drive to set a brave long-term goal, at a time when many other organizations were focused on short-term needs, has provided a rallying point for the Association's millions of volunteers and donors. Nancy has also led the organization to a number of significant advances in the time that she has served as its top staff executive; these include a laser focus on prevention and the benefits of preventive health as outlined in the AHA's 2010–13 strategic plan, creating the Vision for Volunteerism initiative to generate even more significant opportunities for volunteers to impact the AHA's mission, development of the first-ever integrated global strategy for the AHA, launching new programs to expand individual giving and increase the AHA's revenue and mission impact in small communities and instilling a culture of innovation throughout the AHA, spearheaded by the AHA's Innovation Think Tank which is comprised of staff executives and volunteer thought leaders, who have among other things, created the roadmap for future new missions and revenue business enterprises. In addition to her tireless efforts for the AHA, Nancy shares her passion for improving the health of individuals in the U.S. and globally by serving on the boards of the Campaign for Tobacco Free Kids, the National Health Council, Research! America and the Partnership for Prevention. She was also recently appointed co-chairman of the Coalition to Transform Advanced Care, which is being convened to reframe how to provide end of life care that respects patients’ wishes and ensures quality decision-making and outcomes for families and health care providers. Prior to being named CEO, Nancy served as AHA's chief operating officer for the eight prior years. In this role she managed the AHA's mission, science and business functions and led the AHA's integrated strategy to achieve its 2010 Impact Goal to reduce coronary heart disease, stroke and risk by 25%. She has held multiple leadership positions at the AHA since her start in 1986 leading fundraising initiatives in the Michigan affiliate, including serving as the executive director in Metro Detroit, as well as leading the AHA's work as executive vice president of the former Massachusetts and New England affiliates. Prior to joining the AHA, Nancy served her home state of Michigan as director of development/deputy director of the Endowment Campaign for the Michigan Cancer Foundation, and as special events director for Mount Carmel Mercy Hospital in Detroit.back to top
Ben Chu, MDGroup President, Southern California and Hawaii, Kaiser Permanente
Benjamin Chu, MD, MPH, MACP, was appointed regional president of Kaiser Permanente Southern California in February 2005 and in January 2011 was appointed group president responsible for both Southern California and Hawaii. He directs hospital and health plan operations for 14 hospitals and 145 medical offices, serving more than 3.45 million members. As group president, he joins the Kaiser Permanente Program-wide Operational Leadership group with oversight responsibility over the entire organization. Before he joined Kaiser Permanente, Dr. Chu served for three years as president of New York City’s Health and Hospitals Corp., the largest public hospital system in the country. A primary care internist by training, Dr. Chu possesses extensive health care experience as a clinician, administrator and policy advocate. He was senior vice president for Medical and Professional Affairs for the public hospitals and served as acting commissioner of health for the New York City Department of Health from 1990 to 1994. Dr. Chu has experience as an academic health center leader. He was senior associate dean at Columbia University College of Physicians and Surgeons from July 2000 to February 2002. He also served at the New York University School of Medicine and Medical Center as associate dean and Vice President for Clinical Affairs from April 1994 to May 2000. As a 1989–1990 Robert Wood Johnson Policy Fellow, he served as a legislative assistant for health for New Jersey Senator Bill Bradley. Dr. Chu currently serves on the board of the Commonwealth Fund in New York and is chairman of the board of the American Legacy Foundation based in Washington, DC. In 2008, he completed a three-year term as an at-large board member of the American Hospital Association, serving on the executive committee during the final year. He is currently an AHA appointee to the Joint Commission Board. Dr. Chu earned his medical degree at New York University, his master’s of public health from Columbia University and a bachelor’s degree in psychology from Yale University.back to top
Peter Diamandis, MDChairman and CEO, the X PRIZE Foundation
Peter Diamandis, MD, is the chairman and CEO of the X PRIZE Foundation, a 501c (3) non-profit focused on designing and launching global incentive prizes to drive radical breakthroughs for the benefit of humanity. Best known for the $10 million Ansari X PRIZE for private spaceflight, the Foundation is now launching prizes in five Prize Groups: Exploration, Life Sciences, Energy & Environment, Education, and Global Development. Today, the X PRIZE has three active prizes: the $10 million Archon Genomics X PRIZE presented by Express Scripts, the $30 million Google Lunar X PRIZE, and the $10 million Qualcomm Tricorder X PRIZE. Dr. Diamandis is also international leader in the commercial space arena, having founded and run many of the leading entrepreneurial companies in this sector. Dr. Diamandis serves as co-founder and managing director of Space Adventures (www.spaceadventures.com), the only company to have brokered the launches of private citizens to the International Space Station. He is co-founder and CEO of Zero Gravity Corporation (www.gozerog.com), a commercial space company developing private, FAA-certified parabolic flight utilizing a Boeing 727-200 aircraft. He is also the chairman and co-founder of the Rocket Racing League (www.rocketracingleague.com). In 2008, he co-founded Singularity University (www.singularityU.org) where he serves as vice-chancellor and chairman. In 1987, Dr. Diamandis co-founded the International Space University (ISU) (www.isunet.edu) where he served as the University’s first managing director. Prior to ISU, Dr. Diamandis served as chairman of Students for the Exploration and Development of Space (SEDS) an organization he founded at Massachusetts Institute of Technology (MIT) in 1980. His accolades include the 2007 Arthur C. Clarke Award for Innovation, the 2006 (inaugural) Heinlein Award, the 2006 Lindbergh Award, the 2006 Wired RAVE Award, the 2006 Neil Armstrong Award for Aerospace Achievement and Leadership, the Konstantine Tsiolkovsky Award, two-time winner of the Aviation & Space Technology Laurel, and the 2003 World Technology Award for Space. In 8th grade, while living in New York, Dr. Diamandis won first place in the Estes rocket design contest. Dr. Diamandis attended the MIT where he received his undergraduate degree in molecular genetics and graduate degree in aerospace engineering. After MIT, he attended Harvard Medical School where he received his MD. In 2005, he was awarded an honorary Doctorate from the International Space University.back to top
John DriscollCEO, CareCentrix
John Driscoll brings more than 25 years of health care experience to CareCentrix as CEO. Prior to CareCentrix, John served as president at Castlight Health, a healthcare technology company. Previously John served as group president for new markets at Medco and led product development for Medco’s employer and health plan clients. Mr. Driscoll was responsible for corporate development and led Medco’s entry into Medicare, international markets and pharma services.
Mr. Driscoll founded and chaired the Surescripts ePrescribing Network. He also served as an advisor to Oak Investment Partners, and held a number of senior operating positions at Oxford Health Plans, including corporate vice president for government programs.
John has a B.A. and M.B.A. from Harvard University as well as an M.Phil from Cambridge University in England. John is the chairman of the Truman National Security Project and is an advisory board member of Bread for the World.back to top
Kieran GallahueChairman and CEO, CareFusion
Kieran Gallahue is chairman and chief executive officer of CareFusion, a global health care company with products and services that help hospitals measurably improve the safety, quality and cost of patient care. Previously, Kieran served as president, CEO and a director of ResMed, a global leader in medical equipment for treating, diagnosing and managing sleep-related respiratory disorders. He has approximately 20 years of strategic, operational and corporate management experience in the health care industry, with deep expertise in the medical technologies field. Since 2007, he has also served on the board of Volcano Corp., a developer of products for interventional cardiology. He also serves on the Executive Committee of the board of the Advanced Medical Technology Association (AdvaMed) and has been a member of the Young Presidents Organization since 2002. Prior to joining ResMed, Kieran held various general management and functional roles at Nanogen, Instrumentation Laboratory, P&G and GE. Kieran holds a Bachelor of Science degree in economics from Rutgers University and an MBA from Harvard Business School.back to top
Major General Elder Granger, MDUS Army (Retired); Former Deputy Director, TRICARE Management Activity, Office of the Assistant Secretary of Defense for Health Affairs
In July of 2009 after 37 years of military service, Major General Elder Granger retired as the deputy director and program executive officer of the TRICARE Management Activity, Office of the Assistant Secretary of Defense (Health Affairs), Washington, DC. In this role, he served as the principal advisor to the Assistant Secretary of Defense (Health Affairs) on DoD health plan policy and performance. He oversaw the acquisition, operation and integration of DoD's managed care program within the Military Health System. MG Granger led a staff of 1,800 in planning, budgeting and executing a $19 billion Defense Health Program and in ensuring the effective and efficient provision of high-quality, accessible health care for 9.4 million Uniformed Service members, their families, retirees and others located worldwide. Prior to joining TRICARE Management Activity, MG Granger led the largest US and multi-national battlefield health system in recent history while serving as Commander, Task Force 44th Medical Command and Command Surgeon for the Multinational Corps Iraq. He has led at every level of the Army Medical Department. MG Granger began his career with the Army Medical Department in 1971 as a Combat Medic in the U.S. Army National Guard. He earned a Bachelor of Science degree from Arkansas State University in 1976. A Distinguished Military Graduate, MG Granger was commissioned through the Reserve Officer Training Corps. Upon graduation from the University of Arkansas School of Medicine in 1980, he was awarded the Henry Kaiser Medical Fellowship for Medical Excellence and Leadership. MG Granger completed a residency in internal medicine in 1983 and a fellowship in hematology-oncology in 1986 at Fitzsimons Army Medical Center. His military education includes the Army War College, the Army Command and General Staff College, the Army Medical Department Officer Advanced and Basic Courses, the Military Health System and Army CAPSTONE Courses and the Combat Casualty Care Course. MG Granger continues to advance his passion for patients and health care improvement through advising and supporting teams across the spectrum of health care.back to top
Matthew HoltBlogger/Founder, Health 2.0
Matthew Holt has been in health care for over 20 years as a researcher, generalist forecaster and strategist. He is known for his work with some of the best forecasting and survey research organizations in the US including the Institute for the Future and Harris Interactive. He has conducted in-depth studies about many aspects of health care for public release and private clients. He is a well-regarded and amusing presenter and has delivered several keynote addresses. These days, Matt is best known for two things: being the founder (and now occasional) author of The Health Care Blog, which is one of the best-read blogs in health care. His day job is the co-chairman (with Indu Subaiya) of Health 2.0, the leading venue for innovative technology in health care. Health 2.0 has a large annual conference in the U.S. with other franchise conferences across the U.S. and abroad. It also offers a market intelligence and advisory service, its own media and TV channel, a platform for prize challenges and a large community of followers with chapters in more than 30 cities worldwide.back to top
James HummerFounder, Luxemburg Capital; Former CEO, Whole Health Management
James Hummer ran Whole Health Management for 12 years. He was one of the first to see the opportunity in helping self-insured employers bring their health care services "into the tent." Whole Health originated as an on-site health provider to the federal sector. James purchased the business in 1987, renamed it in 1991, and by the time he sold it to Walgreens in March 2008, he was running 70 clinics for private-sector employers, including Continental Airlines, Sprint and Qualcomm. Whole Health is now part of Walgreens' Take Care Employer Solutions unit. Previously, James founded IVY Medical Group, a large ambulatory care practice and was also involved with Simplicity Health Plans. Named regional Ernst & Young Entrepreneur of The Year in 2008, James now invests in health care startups through Luxemburg Capital.back to top
Don JonesCEO, Trial Fusion
Donald Jones is a globally recognized leader in Digital Medicine (sometimes referred to as Wireless Health, Digital Health, Connected Health, or mHealth). He is sought out as a speaker, advisor and board member. He works with healthcare, pharmaceutical and medical device, OEM, Telcos and early stage companies. Donald Jones is the CEO of Trial Fusion, a company focused on commercializing digital health products by providing design and partnership expert advise and clinical, user experience and economic evidence required for their adoption. Jones also serves as the Chief Digital Officer of the Scripps Translational Science Institute, working with the renowned Eric Topol, MD, on the convergence of genomics and wireless health – digital medicine. He co-founded Scripps Digital Medicine, the world’s first clinical trial center focused on digital health and large data sets. For 11 years through 2014, he led Wireless Health Global Strategy and Business Development for Qualcomm. He is Founder and Chairman of the Wireless Life Sciences Alliance. Working with the XPRIZE Foundation and Qualcomm’s CEO, Jones conceived the $10 million Qualcomm Tricorder XPRIZE, a global competition for a consumer device which makes medical diagnoses. CommNexus recognized Donald Jones as 2014 Digital Health Innovator of the Year.back to top
Dean KamenInventor and Founder, DEKA Research and Development Corporation
Dean Kamen is an inventor, entrepreneur and tireless advocate for science and technology. His roles as inventor and advocate are intertwined—his own passion for technology and its practical uses has driven his personal determination to spread the word about technology's virtues and by so doing to change the culture of the U.S. As an inventor, he holds more than 440 U.S. and foreign patents, many of them for innovative medical devices that have expanded the frontiers of health care worldwide. While still a college undergraduate, he invented the first wearable infusion pump, which rapidly gained acceptance from such diverse medical specialties as chemotherapy, neonatology and endocrinology. In 1976, he founded his first medical device company, AutoSyringe, Inc., to manufacture and market the pumps. At age 30, he sold that company to Baxter Healthcare Corporation. By then, he had added a number of other infusion devices, including the first wearable insulin pump for diabetics. Following the sale of AutoSyringe, Inc., he founded DEKA Research and Development Corporation to develop internally generated inventions as well as to provide research and development for major corporate clients. Kamen led DEKA's development of the HomeChoice™ peritoneal dialysis system for Baxter International Inc. The HomeChoice system allows patients to be dialyzed in the privacy and comfort of their home and quickly became the worldwide market leader. Dean also led the development of technology to improve slide preparation for the CYTYC (now Hologic Inc.) ThinPrep® Pap Test. Kamen-led DEKA teams have also developed critical components of the UVAR™ XTS™ System, an extracorporeal photophereisis device marketed by Therakos, a unit of Johnson & Johnson, for treatment of T-cell lymphoma. An advanced prosthetic arm in development for DARPA should advance the quality of life for returning injured soldiers. Other notable developments include the Hydroflex™ surgical irrigation pump for C.R. Bard, the Crown™ stent, an improvement to the original Palmaz-Schatz stent, for Johnson & Johnson, the iBOT™ mobility device, and the Segway® Human Transporter. Dean has received many awards for his efforts. Notably, he was awarded the National Medal of Technology in 2000. Presented by President Clinton, this award recognizes inventions that have advanced medical care worldwide, and for innovative and imaginative leadership in awakening America to the excitement of science and technology. Dean was also awarded the Lemelson-MIT Prize in 2002, and was inducted into the National Inventors Hall of Fame in May 2005. In addition to DEKA, one of Dean's proudest accomplishments is founding FIRST® (For Inspiration and Recognition of Science and Technology), an organization dedicated to motivating the next generation to understand, use and enjoy science and technology. Founded in 1989, this year FIRST will serve more than 250,000 young people, ages 6 to 18, in more than 50 countries around the globe. High school-aged participants are eligible to apply for more than $14 million in scholarships from leading colleges, universities and corporations. Studies have shown that FIRST alumni are highly motivated to pursue careers in science and engineering, thus fulfilling Dean's goal of inspiring the next generation of technological leaders.back to top
Francine Kaufman, MDFormer President, National Diabetes Association; Chief Medical Officer and Vice President of Global Clinical, Diabetes, Medtronic
Francine Ratner Kaufman, MD has had a 30 year distinguished career in diabetes care, research and advocacy. In 2009, she stepped down as director of the Comprehensive Childhood Diabetes Center, and head of the Center for Endocrinology, Diabetes and Metabolism at Children’s Hospital Los Angeles to become chief medical officer and VP of Global Clinical, Medical and Health affairs at Medtronic Diabetes (Northridge, Calif.). Dr. Kaufman is also a Distinguished Professor Emerita of Pediatrics and Communications at the Keck School of Medicine and the Annenberg School of Communications of the University of Southern California, and an attending physician at Children’s Hospital Los Angeles. Dr. Kaufman has published more than 200 peer-reviewed and invited publications. She is the author of more than 30 books or book chapters. In 2008, she edited the 5th edition of the ADA’s Medical Management of Type 1 Diabetes. In 2005 her book, Diabesity, was published by Bantam. Diabesity explores the ravages of the obesity and diabetes epidemics as they spread across the globe. Dr. Kaufman was chair of the National Institutes of Health funded Studies to Treat (the TODAY Trial) and Prevent (the HEALTHY Trial) Type 2 Diabetes in Youth (STOPP-T2). She was a principal investigator of TrialNet, a multinational consortium evaluating ways to prevent Type 1 diabetes, funded by the National Institutes of Health (NIH). She has received many awards and honors, including the LA City Council for promoting youth physical fitness (2004), from the State of California for her role in banning sodas from Los Angeles Unified School District (2003) and from the American Diabetes Association (ADA), Juvenile Diabetes Research Foundation (JDRF), European Association for the Study of Diabetes (EASD), Partners in Care, and Starbright Foundation, amongst others. In 2009, Dr. Kaufman was elected to membership in the Advisory Council of the Diabetes Branch of the NIH. In 2007, she filmed a documentary for Discovery Health on the global diabetes epidemic, which was aired around the world on World Diabetes Day, November 14, 2007. Also in 2007, Dr. Kaufman was co-chair of the Diabetes Work Group for the Department of Health Services of the State of California to recommend diabetes treatment and prevention strategies for the Medicaid population. In 2005, she was elected membership in the Institute of Medicine. Dr. Kaufman was national president of the American Diabetes Association in 2002-03. She was elected to the AOA Medical Honorary Society. She was also president of Shaping America’s Health, chair of the National Diabetes Education Program, and served as chair of the Youth Consultative Section of the International Diabetes Federation.back to top
Ilene Klein, MD, FAAFP (Chair)Chief Medical Advisor, Qualcomm Life, Inc.; Director of Global Employee Health Services, Qualcomm, Inc.
Ilene serves as the chief medical advisor for Qualcomm Life and director of global employee health services for Qualcomm, Inc. Ilene has more than 30 years of administrative and clinical experience in the public and private health care sectors. As the former deputy director of operations for the New York City Department of Health’s Bureau of Child Health, Ilene helped to create a city-wide network of pediatric primary care homes in underserved communities. After pursuing a career in clinical medicine, she was a partner in a private family practice in Massachusetts. There she served as the first chief of service for the new Department of Primary Care at Martha’s Vineyard Hospital. Ilene came to San Diego in 2007 to open Qualcomm’s first onsite employee health center, where she served as its medical director until June 2011. Ilene is a board- certified family physician and a Fellow of the American Academy of Family Physicians. She earned her medical degree from Harvard Medical School, where she was an Edward Kass Fellow at the East Boston Neighborhood Health Centre. She completed her residency training through the Department of Family Medicine at Brown University. Ilene holds bachelors and master’s degrees in music therapy from New York University.back to top
Isaac Kohane, MDDirector of the Children's Hospital Informatics Program; Henderson Professor of Pediatrics and Health Sciences and Technology, Harvard Medical School
Isaac (Zak) Kohane, MD, is the director of the Children's Hospital Informatics Program and is the Henderson Professor of Pediatrics and Health Sciences and Technology at Harvard Medical School (HMS). He is also co-director of the HMS Center for Biomedical Informatics and Director of the HMS Countway Library of Medicine. Dr. Kohane leads multiple collaborations at Harvard Medical School and its hospital affiliates in the use of genomics and computer science to study cancer and the development of the brain, with an emphasis on autism. He has developed several computer systems to allow multiple hospital systems to be used as "living laboratories" to study the genetic basis of disease, while preserving patient privacy. Dr. Kohane's research builds on his doctoral work in computer science on decision-support and subsequent research in machine-learning applied to biomedicine. Dr. Kohane has led the development of cryptographic health identification systems, automated personal health records and peer-to-peer pathology information networks. Dr. Kohane leads several NIH-funded efforts to translate genomic research into clinical practice and continues his own practice in pediatric endocrinology at Children's Hospital Boston.back to top
Daniel Kraft, MDFounder, FutureMed
Daniel Kraft, MD, is a Stanford and Harvard-trained physician-scientist, inventor, entrepreneur and innovator. Dr. Kraft has over 20 years of experience in clinical practice, biomedical research and health care innovation. Daniel chairs the Medicine track for Singularity University and is executive director for FutureMed, a program that explores convergent, exponentially developing technologies and their potential in biomedicine and health care. Following his undergraduate degree at Brown and medical school at Stanford, Dr. Kraft was board certified in the Harvard combined internal medicine and pediatrics residency program at Massachusetts General Hospital and Children’s Hospital Boston. He went on to complete Stanford fellowships in hematology/ oncology and bone marrow transplantation, and extensive research in stem cell biology and regenerative medicine. He has multiple scientific publications (including in Nature and Science) and medical device, immunology and stem cell-related patents through faculty positions with Stanford University School of Medicine and as clinical faculty for the pediatric bone marrow transplantation service at UCSF. Dr. Kraft recently founded IntelliMedicine, focused on enabling connected, data-driven and integrated personalized medicine. He is also the inventor of the MarrowMiner, an FDA-approved device for the minimally invasive harvesting of bone marrow, and founded RegenMed Systems, a company developing technologies to enable adult stem cell-based regenerative therapies. Daniel is an avid pilot and serves in the California Air National Guard as an officer and flight surgeon with an F-16 fighter squadron. He has conducted research on aerospace medicine that was published with NASA, with whom he was a finalist for astronaut selection.back to top
Joseph Kvedar, MDDirector, Center for Connected Health, Partners HealthCare
Joseph Kvedar, MD, is the founder and director of the Center for Connected Health at Partners Healthcare, which works to create a new model of health care delivery by developing programs and innovative strategies to move care from the hospital or doctor’s office into the day-to-day lives of patients. In his role with the Center for Connected Health, Dr. Kvedar is creating innovative programs to leverage information technology—cell phones, computers, networked devices and simple remote health monitoring tools—to help providers and patients manage chronic conditions, maintain health and wellness and improve adherence, engagement and clinical outcomes. Based on the technology platform developed at the Center, Healthrageous, a personalized health technology company, was launched in 2010, offering a range of health and wellness self-management programs to its clients. In addition, Dr. Kvedar also launched the first physician-to-physician online consultation service in an academic setting, which today electronically links patients from around the world and their local providers with leading specialists at Harvard-affiliated teaching hospitals. Dr. Kvedar is internationally recognized for his leadership and vision in the field of connected health and the application of communications technologies to improve health care for patients. He is a frequent lecturer and has authored over 70 publications on the subject. Dr. Kvedar serves as a board member for a number of organizations, including the Continua Health Alliance and the Care Continuum Alliance. He also is a co-founder of Healthrageous and chair of the company’s Scientific Advisory Board. Dr. Kvedar is a past president and board member of the American Telemedicine Association (ATA) and a past chair of the American Academy of Dermatology (AAD) Task Force on Telemedicine. In 2009, Dr. Kvedar was honored by the ATA with its Individual Leadership Award, recognizing his significant contributions to connected health and telemedicine. Mass High Tech, the Journal of New England Technology named Dr. Kvedar an All-Star in the field of health care and he has been honored by the New England Business and Technology Association for his extraordinary leadership in the field. A division of Partners HealthCare, the Center for Connected Health works with Harvard Medical School-affiliated teaching hospitals, including Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Kvedar is also a board-certified dermatologist and associate professor of dermatology at Harvard Medical School.back to top
Jack Lord, MDChief Operating Officer, University of Miami Miller School of Medicine and UHealth-University of Miami Health System
A nationally recognized leader in innovations in health care, Jonathan “Jack” Lord, MD, became the University of Miami’s chief innovation officer when he returned to his alma mater in September 2011 after three decades in leadership roles that spanned the health care spectrum. In March 2012, he was named chief operating officer of the Miller School of Medicine and UHealth-University of Miami Health System. A board-certified forensic pathologist who began his medical career in the U.S. Navy and later served as chief operating officer of the American Hospital Association and several biotech companies, Dr. Lord was the former chief innovation officer and senior vice president of Humana. During his time at Humana, he created Humana’s Innovation Center, which combines research, technology and consumer experience to promote health and well-being. He also contributed to the field of predictive sciences by using advanced analytics to predict who will become ill in the future and how to prevent disease. Further cementing his ties to UM, he oversaw the creation of the UM/Humana Health Resources Center on the Miller School campus in 2006. Dr. Lord also serves or has served as a member of a number of prestigious boards and organizations, including the Centers for Disease Control and Prevention’s Advisory Committee to the Director; the National Advisory Council for Health Care Research and Quality, which advises the U.S. Secretary of Health and Human Services; and the Joint Commission on Accreditation of Health Care Organizations. He was a member of the President’s Council at UM, an advisory group of some of the University's most prominent alumni. His previous academic appointments include Dartmouth Medical School, George Washington University and the Eastern Virginia School of Medicine.back to top
Dana George Mead, Jr.Partner, Kleiner Perkins Caufield & Byers
Dana Mead joined Kleiner Perkins Caufield & Byers as a partner in May 2005 to work in the firm’s life sciences practice. He leverages experience accrued from his venture-funded, startup management roles and board participation to support entrepreneurs and innovators dedicated to making a real difference in the lives of millions suffering from life-limiting diseases. Dana serves on the boards of Apnicure, Awarepoint, Corventis, Inspire Medical Systems, Intersect ENT, Invuity, Pulmonx, Spiracur, Spinal Modulation, and Teladoc. For the past 29 years, Dana’s career has focused on identifying new medical technologies, developing new markets and therapies, and building world-class management teams. He has worked with physician thought leaders around the world representing 10 medical specialties. Before joining KPCB, Dana was president of Guidant Vascular Intervention, a fully integrated billion-dollar division with more than 4,500 employees. He joined Guidant in 1992 and held positions of increasing responsibility during his tenure, including vice president and general manager, Cardiac & Vascular Surgery; vice president and general manager, Stents, Vascular Intervention Group; president, Japan and A/P Operations based in Tokyo; and vice president, Corporate Relations and Policy, with responsibility for investor relations, corporate communications, corporate marketing and public policy initiatives. Earlier in his career, Dana worked in various sales and marketing roles at Allergan, Inc. and Johnson & Johnson. Dana formerly served as a director of the Cardiovascular Research Foundation, Aesthera (acquired by Solta [Nasdaq: SLTM]), OtisMed (acquired by Stryker [Nasdaq: SYK]) and Navigenics (acquired by Life Technologies [Nasdaq: LIFE]). He currently serves on the boards of the California Healthcare Institute and Lucile Packard Children’s Hospital at Stanford University, and he is the chair of the Lafayette College West Coast Advisory Council. A native of Connecticut, Dana received his B.A. degree from Lafayette College and holds an M.B.A from the University of Southern California.back to top
Arnie Milstein, MDMedical Director, Pacific Business Group on Health; Mercer Benefits Consulting; Stanford CERC
Arnie Milstein, MD is a professor of medicine at Stanford and directs the Stanford Clinical Excellence Research Center (CERC). The Center is a collaboration of the Schools of Medicine, Engineering and Business to design and test new health care delivery models that both lower per capita health care spending and improve clinical outcomes. His career and ongoing research is focused on the acceleration of clinical service innovations that improve the societal value of health care. He also serves as the medical director of the Pacific Business Group on Health (PBGH), the largest regional health care improvement coalition in the US. He also guides employer-sponsored, clinically based innovation development for Mercer Health and Benefits and chairs the Steering Committee that directs the largest US physician pay-for-performance program, operated by the Integrated Healthcare Association. Previously he co-founded the Leapfrog Group and Consumer-Purchaser Disclosure Project, and served as a Congressionally-appointed MedPAC Commissioner. Citing his nationally distinguished innovation in health care cost reduction and quality gains, he was selected for the highest annual award of the National Business Group on Health (NBGH) and of the American College of Medical Quality. Elected to the Institute of Medicine (IOM) of the National Academy of Sciences, he chaired the planning committee of its examination of best methods to lower per capita health care spending and improve clinical outcomes. He was educated at Harvard (BA in economics), Tufts (MD) and UC Berkeley (MPH in health services evaluation and planning).back to top
Diego MirallesHead, Janssen Healthcare Innovation; Head, West Coast Research Center; Head, Janssen Labs, Johnson & Johnson
Diego Miralles is the head of External Innovation for the immunology therapeutic area at Johnson & Johnson Pharmaceutical Research & Development. In this role, he is responsible for expanding the immunology R&D network through external partnerships to increase research/development capabilities and the immunology portfolio. Diego graduated from the University of Buenos Aires in 1986. From there, he completed his residency in internal medicine at the Mayo Clinic in Rochester, Minn. (1987–1990) and his fellowship in infectious diseases at Cornell University-New York Hospital (1990–1992). He was attending in charge at The AIDS Clinical Trial Unit, Beth Israel Medical Center, New York in 1993. Diego was also on the faculty at Duke University, Durham, NC, from 1993 to 1998. He continued his academic appointment and clinical HIV practice at Duke from 1993 through 2005. Diego joined Triangle Pharmaceuticals as associate director, and then director, team leader, DMP-450, in 1998–2000. He was then with Trimeris as director/senior director, clinical trials, Clinical Team Leader T-1249, in 2000–2005. He joined Tibotec/Johnson & Johnson in Belgium in June 2005 as VP, Global Clinical Development, where he oversaw the regulatory approval of Prezista and Intelence and was on the company board. Diego has also been head of the Johnson & Johnson Pharmaceutical Research and Development (PRD) Discovery site in San Diego, Calif., since August 2008.back to top
Jean RawlingsChief Consumer Strategist, UnitedHealth Group IT
Jean Rawlings has nearly 30 years of experience solving business and technical challenges in the health care industry. For the past 11 years, she has been a leader in innovation across UnitedHealth Group, most recently leading the Advanced Computations Lab as the chief consumer strategist. In this capacity, Jean designs vision and strategy for new technologies, combining technical talent and business expertise to enable the Advanced Computations Lab to quickly connect information and functionality to invent ground-breaking analytic capabilities and technologies. During her 11 years with UnitedHealth Group, she has helped design and patent several first-to-market analytic products including i3 Aperio®, Ingenix Best Match Search, the Ingenix CRAFT™ research tool, Ingenix Aberrancy Tracking Tool, HealthImpact™, The Health Care Index, Attitudinal Segmentation, and The Natural History of Disease, among others. In addition to her work at UHG, her experience includes specialized Continuous Quality Improvement (CQI) training, negotiating provider network contracts between large national payers and large hospital/physician organizations, monitoring and analyzing local and national trends and legislation to discern their impact on the health care industry, and medical expense management and consulting.back to top
Lee ShapiroPresident, Allscripts
Lee oversees the company's strategy, government relations, mergers and acquisitions, international operations, business development and partnerships, health plan initiatives and business activities in the areas of analytics and information services. He also serves as executive sponsor for Allscripts key strategic relationships with companies such as Microsoft, Dell, Fujitsu, Henry Schein and Intuit. Since becoming president of Allscripts in 2001, Lee has led a team that develops the network of alliances that are and will continue to be critical to the company's success, with the goal of improving solutions, expanding offerings, enhancing market presence and broadening opportunities. Prior to joining Allscripts, Lee was the chief operating officer of Douglas Elliman-Beitler, a premier commercial office management and development company, where he directed all business activities throughout the United States. Lee also previously served as president of SES Properties, Inc., a closely held, fully integrated real estate company and, at that time, the largest retail developer in Las Vegas. Concurrently, Lee formed City Financial Bancorp and served as its vice chairman. He was responsible for the acquisition of financial institutions, financing, regulatory issues, legal affairs and the restructuring of operations, leading to the ultimate sale of this $100 million holding company. Lee serves on the boards of Medidata Solutions [Nasdaq:MDSO], Perseus Acquisition LLC (Physicians Interactive) and the Kellogg Innovation Network Advisory Board of the Kellogg School of Management, Northwestern University. Lee was appointed by Governor Quinn to the Illinois Economic Recovery Commission in 2009. He is also an officer and director of the Gastro-Intestinal Research Foundation (GIRF). Lee practiced commercial law at Barack, Ferrazzano, Kirschbaum, Perlman and Nagelberg, a prominent Chicago law firm. He holds a JD degree from the University of Chicago Law School.back to top
Larry SmarrFounder, California Institute for Telecommunications and Information Technology (Calit2), University of California, San Diego
Larry Smarr is the founding director of the California Institute for Telecommunications and Information Technology (Calit2), a UC San Diego/UC Irvine partnership. He also holds the Harry E. Gruber Professorship in Computer Science and Engineering (CSE) at UCSD's Jacobs School. At Calit2, Larry has continued to drive major developments in information infrastructure—including the Internet, Web, scientific visualization, virtual reality and global telepresence. During his previous 15 years as founding director of the National Center for Supercomputing Applications (NCSA), Larry served as principal investigator on NSF's OptIPuter project and currently is principal investigator of the Moore Foundation's CAMERA project and co-principal investigator on NSF's GreenLight project. In October 2008 he was the Leadership Dialog Scholar in Australia.back to top
Mark Smith, MDPresident and CEO, California HealthCare Foundation
Mark Smith, MD, has been president and chief executive officer of the California HealthCare Foundation (CHCF) since its founding in 1996. CHCF is an independent philanthropy with assets of more than $700 million, headquartered in Oakland, Calif., and dedicated to improving the health of the people of California through its program areas: Better Chronic Disease Care, Innovations for the Underserved, Market and Policy Monitor and Health Reform and Public Programs Initiative. A board certified internist, Dr. Smith is a member of the clinical faculty at the University of California, San Francisco and an attending physician at the Positive Health Program (for AIDS care) at San Francisco General Hospital. He has been elected to the Institute of Medicine, National Academy of Sciences and appointed as chair to the committee, “Learning Healthcare System in America.” Prior to joining the California HealthCare Foundation, Smith was executive vice president at the Henry J. Kaiser Family Foundation. He previously served as associate director of AIDS Services and assistant professor of medicine and of health policy and management at Johns Hopkins University. He has served on the Performance Measurement Committee of the National Committee for Quality Assurance, the Board of the National Business Group on Health, and the Editorial Board of the Annals of Internal Medicine. Dr. Smith received a bachelor's degree in African-American studies from Harvard College, a medical doctorate from the University of North Carolina at Chapel Hill and an MBA with a concentration in health care administration from the Wharton School at the University of Pennsylvania.back to top
Lisa SuennenManaging Partner at Venture Valkyrie Consulting, LLC
Lisa Suennen is Managing Partner at Venture Valkyrie Consulting, LLC, a consulting firm providing advisory services to companies, organizations and private equity firms in the healthcare field.
Additionally, Lisa is a Senior Advisor to Psilos Group, a healthcare-focused venture capital and growth equity firm that focuses on the healthcare information technology, healthcare services and medical device sectors. Lisa was a co-founder of Psilos Group and a Partner at the firm from 1998-2014.
Prior to Psilos, Lisa was at Merit Behavioral Care (formerly American Biodyne, Inc), an $800mm behavioral healthcare company where she held various senior executive roles from its early start-up days through exit. Previously, Lisa held various positions in marketing and product management in companies in the high technology field.
Lisa is currently a a Board Member of the Dignity Health Foundation, and Board Member of health IT company Beyond Lucid Technologies, a Board Member of medical device company AngioScore, a member of the Qualcomm Life Advisory Board, and an Advisor to the California Health Care Foundation Innovation Fund. Lisa also serves as an Advisor to innovation consulting firm Accelevate, Inc. She previously served as a member of the Advisory Board of the U.S. Health and Human Services Office of the National Coordinator Investing in Innovations program.
Lisa holds an M.A. in political science, a B.A. in political science and a B.A. in mass communications, all from the University of California, Berkeley, where she is now Vice Chair of the National Advisory Council of the Institute of Governmental Studies at the University. Lisa is also a visiting lecturer at the U.C. Berkeley Haas School of Business where she teaches the annual course on healthcare venture capital.
Lisa also writes a widely read blog on healthcare and healthcare investing at www.venturevalkyrie.com. She has recently published her first book, entitled: Tech Tonics, Can Passionate Entrepreneurs Heal Healthcare with Technology, coauthored with Dr. David Shaywitz.
Halle TeccoFounder & CEO, RockHealth
Halle Tecco is the Founder & CEO of RockHealth, the first startup accelerator devoted exclusively to health companies. Tecco recognized the need and potential for startups in the digital health space while working at Apple's App Store covering the health vertical. Tecco was named as one of “12 Entrepreneurs Reinventing Healthcare” by CNN and one of “15 Women to Watch in Tech” by Inc. Magazine. She has an MBA from Harvard Business School.back to top
Eric Topol, MDDirector, Scripps Translational Science Institute
Eric Topol, MD, is an innovator and pioneer in the fields of wireless medicine and genomics. In addition to serving as co-founder and vice chairman of the West Health Institute, he is the director of the Scripps Translational Science Institute, a National Institute of Health-funded program of the Clinical and Translational Science Award Consortium. He is also professor of genomics at The Scripps Research Institute; chief academic officer and holder of the Gary and Mary West Chair of Innovative Medicine at Scripps Health; and a senior consultant cardiologist practitioner at Scripps Clinic. Dr. Topol formerly served on the faculty of Case Western Reserve University as a professor in genetics, chaired the Department of Cardiovascular Medicine at Cleveland Clinic for 15 years and founded the Cleveland Clinic Lerner College of Medicine. His work in the genomics of heart attack led to the discovery of key genes, which were recognized among the American Heart Association’s Top 10 research advances in 2002 and 2004. Dr. Topol has been elected to the Institute of Medicine of the National Academy of Sciences, named as one of the 12 “Rock Stars of Science” in GQ and one of the Top 100 Most Influential People in Health Care in 2011, and is recognized by the Thomson-Reuters Institute of Scientific Information as one of the Top 10-cited biomedical researchers in medicine in the past decade.back to top
Dr. Chris WasdenExecutive Director, Sorenson Center for Discovery and Innovation, University of Utah
Dr. Chris Wasden is the Executive Director of the Sorenson Center for Discovery and Innovation at the University of Utah. Previously he was a Managing Director at PwC and the Global Healthcare Innovation Leader. As a global thought leader on Digital Health and the role that Social, Mobile, Analytic and Cloud technologies are transforming healthcare he has written and published over 40 articles and reports on the topic, and he speaks at over 30 events each year on how Digital Health is transforming the practice of medicine, the delivery of care, and the creation of an entirely new wellness paradigm based upon objective measures that lead to greater engagement and changes in human behavior. He advises leading companies on how mobile sensors and Digital Health innovations can create new markets and opportunities (AT&T, Telefonica, Vodafone, Swisscom, Sharp, HCSC, Nokia, RIM, Roche Diagnostics, Eisai Pharmaceuticals, Genentech, Partners Healthcare, just to name a few). He is a named inventor on 11 issued patents and has been a leader in 10 different startups where he developed many of his ideas around the innovation cycle and lifecycle and how fast, frequent, frugal, and failure accelerates innovation. Dr. Wasden has a doctorate in human and organizational learning from George Washington University in Washington, DC, an MBA from the UCLA Anderson School, and bachelor degrees in accounting (BS) and Asian studies (BA) from Brigham Young University in Provo, Utah.back to top
Andrew Rose Watson, MD, MLitt, FACSCMIO, University of Pittsburgh Medical Center
Dr. Andrew Rose Watson is a native of Pittsburgh. He is a fourth generation surgeon and the seventh in his family. He received his Master’s degree at the University of Oxford in England and later attended medical school at Columbia University’s College of Physicians. He returned to UPMC for his surgical training where he completed a minimally invasive surgical fellowship. He is an actively practicing surgeon in the division of Colorectal Surgery and specializes in minimally invasive colorectal and inflammatory bowel disease surgery.
Dr. Watson focuses the majority of his time on corporate health care at UPMC, a $11 billion integrated global delivery system in Pittsburgh. Dr. Watson is the Medical Director for UPMC Telemedicine. He practices 30% of his clinical care using telemedicine that includes multisite remote clinics and inpatient telerounding. He has extensive knowledge of the business of health care and health care IT. He is the Chief-Medical Information Officer of UPMC’s International and Commercial Services Division. In that role he focuses on international business development, and health care delivery with a specialization in telemedicine.
He is the Medical Director and the initial employee of the Center for Connected Medicine, a thought leadership center showcasing the transformation of health care and the creation of a connected medicine strategy. This is the largest collaborative executive briefing center in the United States located in UPMC’s executive headquarters in Pittsburgh. The Center is a joint venture between founding partners UPMC, IBM, GE, ALU and Verizon, and nine strategic partners. Dr. Watson has hosted over 600 tours for over 8,000 visitors from around the world.
John WilbanksSenior Fellow in Entrepreneurship, Kauffman Foundation
John Wilbanks is a senior fellow in Entrepreneurship with the Ewing Marion Kauffman Foundation. He works on open content, open data and open innovation systems. John also serves as a research fellow at Lybba. He has worked at Harvard Law School, MIT’s Computer Science and Artificial Intelligence Laboratory, the World Wide Web Consortium, the US House of Representatives and Creative Commons, as well as starting a bioinformatics company. He sits on the Board of Directors for Sage Bionetworks, iCommons, and 1DegreeBio, and on the Advisory Board for Boundless Learning. John holds a degree in philosophy from Tulane University and also studied modern letters at the University of Paris (La Sorbonne).